Found: 108
Select item for more details and to access through your institution.
A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non‐small‐cell lung cancer: Experience at a single institution.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 5, p. 349, doi. 10.1002/ajh.20569
- By:
- Publication type:
- Article
Impact of HER2 and EGFR gene status on gefitinib-treated patients with nonsmall-cell lung cancer.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 5, p. 1162, doi. 10.1002/ijc.22818
- By:
- Publication type:
- Article
The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 6, p. 1239, doi. 10.1002/ijc.22513
- By:
- Publication type:
- Article
Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
- Published in:
- Annals of Thoracic & Cardiovascular Surgery, 2018, v. 24, n. 3, p. 131, doi. 10.5761/atcs.oa.18-00027
- By:
- Publication type:
- Article
Three doses of mRNA COVID‐19 vaccine protects from SARS‐CoV‐2 infections in Japan.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 4, p. 687, doi. 10.1111/joim.13526
- By:
- Publication type:
- Article
Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer.
- Published in:
- Internal Medicine, 2024, v. 63, n. 9, p. 1261, doi. 10.2169/internalmedicine.2429-23
- By:
- Publication type:
- Article
Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy.
- Published in:
- Internal Medicine, 2023, v. 62, n. 9, p. 1319, doi. 10.2169/internalmedicine.0505-22
- By:
- Publication type:
- Article
Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan.
- Published in:
- Internal Medicine, 2022, v. 61, n. 3, p. 379, doi. 10.2169/internalmedicine.7124-21
- By:
- Publication type:
- Article
Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease.
- Published in:
- Internal Medicine, 2021, v. 60, n. 17, p. 2831, doi. 10.2169/internalmedicine.6470-20
- By:
- Publication type:
- Article
Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2012, v. 15, n. 6, p. 954, doi. 10.1093/icvts/ivs412
- By:
- Publication type:
- Article
Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression.
- Published in:
- Oncology Letters, 2021, v. 22, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12900
- By:
- Publication type:
- Article
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12256
- By:
- Publication type:
- Article
Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0285273
- By:
- Publication type:
- Article
Triplet therapy with afatinib, cetuximab, and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 6, p. 670, doi. 10.1002/1878-0261.12063
- By:
- Publication type:
- Article
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1354, doi. 10.1007/s10147-023-02390-2
- By:
- Publication type:
- Article
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 7, p. 1139, doi. 10.1007/s10147-022-02164-2
- By:
- Publication type:
- Article
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 695, doi. 10.1007/s10147-022-02120-0
- By:
- Publication type:
- Article
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 6, p. 1073, doi. 10.1007/s10147-021-01899-8
- By:
- Publication type:
- Article
Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 11, p. 1367, doi. 10.1007/s10147-019-01508-9
- By:
- Publication type:
- Article
Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 461, doi. 10.1007/s10147-019-01424-y
- By:
- Publication type:
- Article
Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 1, p. 41, doi. 10.1007/s10147-018-1344-x
- By:
- Publication type:
- Article
Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 2, p. 274, doi. 10.1007/s10147-016-1067-9
- By:
- Publication type:
- Article
Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 1, p. 81, doi. 10.1007/s10147-015-0860-1
- By:
- Publication type:
- Article
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intolerance.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4933, doi. 10.1007/s00432-022-04415-1
- By:
- Publication type:
- Article
First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 8, p. 1869, doi. 10.1007/s00432-021-03893-z
- By:
- Publication type:
- Article
Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3749, doi. 10.1007/s00432-021-03615-5
- By:
- Publication type:
- Article
Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
- By:
- Publication type:
- Article
Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non—Small-Cell Lung Cancer: Study Protocol.
- Published in:
- Clinical Lung Cancer, 2017, v. 18, n. 1, p. 92, doi. 10.1016/j.cllc.2016.06.014
- By:
- Publication type:
- Article
Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR‐mutated lung cancer and pulmonary tuberculosis: A case report.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 17, p. 1390, doi. 10.1111/1759-7714.15324
- By:
- Publication type:
- Article
Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 3, p. 249, doi. 10.1080/0284186X.2019.1695062
- By:
- Publication type:
- Article
Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 6, p. 768, doi. 10.3109/0284186X.2011.648342
- By:
- Publication type:
- Article
Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 4, p. 537, doi. 10.3109/0284186X.2011.631580
- By:
- Publication type:
- Article
A case of advanced non-small-cell lung cancer who responded slowly to gefitinib monotherapy after long-term disease stabilization.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 3, p. 471, doi. 10.1080/02841860802425310
- By:
- Publication type:
- Article
Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group Experience.
- Published in:
- Acta Oncologica, 2005, v. 44, n. 7, p. 717, doi. 10.1080/02841860500256215
- By:
- Publication type:
- Article
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 2401, doi. 10.2147/DDDT.S71419
- By:
- Publication type:
- Article
Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042798
- By:
- Publication type:
- Article
Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0026646
- By:
- Publication type:
- Article